Publication

Synthesis and evaluation of cryptolepine analogues for their potential as new antimalarial agents.

Wright, Colin W.
Addae-Kyereme, Jonathan A.
Breen, Anthony G.
Brown, John E.
Cox, Marlene F.
Croft, S.L.
Gokcek, Yaman
Kendrick, H.
Phillips, Roger M.
Pollet, Pamela L.
Publication Date
2001
End of Embargo
Supervisor
Rights
Peer-Reviewed
Yes
Open Access status
closedAccess
Accepted for publication
Institution
Department
Awarded
Embargo end date
Additional title
Abstract
The indoloquinoline alkaloid cryptolepine 1 has potent in vitro antiplasmodial activity, but it is also a DNA intercalator with cytotoxic properties. We have shown that the antiplasmodial mechanism of 1 is likely to be due, at least in part, to a chloroquine-like action that does not depend on intercalation into DNA. A number of substituted analogues of 1 have been prepared that have potent activities against both chloroquine-sensitive and chloroquine-resistant strains of Plasmodium falciparum and also have in common with chloroquine the inhibition of ß-hematin formation in a cell-free system. Several compounds also displayed activity against Plasmodium berghei in mice, the most potent being 2,7-dibromocryptolepine 8, which suppressed parasitemia by 89% as compared to untreated infected controls at a dose of 12.5 mg kg-1 day-1 ip. No correlation was observed between in vitro cytotoxicity and the effect of compounds on the melting point of DNA (¿Tm value) or toxicity in the mouse¿malaria model.
Version
No full-text in the repository
Citation
Wright, C.W., Addae-Kyereme, J., Breen, A.G., Brown, J.E. and Cox, M.F. et al. (2001). Synthesis and evaluation of cryptolepine analogues for their potential as new antimalarial agents. Journal of Medicinal Chemistry. Vol. 44, No. 19, pp. 3187-3194.
Link to publisher’s version
Link to published version
Link to Version of Record
Type
Article
Qualification name
Notes